A tariff-related boost to pharmaceutical exports lifted GDP growth to 12.4% in 2025. The economy is projected to contract by 1% in 2026, due to the unwinding of a frontloading of exports, geopolitical uncertainty and higher energy prices. GDP will grow by 2.9% in 2027, helped by an export market recovery. Underpinned by a relatively resilient labour market, modified domestic demand, which controls for the main distortions arising from multinational activity, is projected to moderate but grow by 2.1% in 2026 and 2.5% in 2027.
The fiscal stance is broadly neutral in 2026-27. Explicitly time-bound, broad-based reductions in energy excise duties are among the main recent measures against the energy shock. More targeted measures would preserve price signals and incur a lower fiscal cost. Amid windfall corporate tax gains, a binding domestic fiscal rule will be vital to ensure medium-term fiscal sustainability. Faster permitting processes to accelerate the deployment of renewable generation capacity would enhance energy security.